Literature DB >> 33523440

Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Yang Du1,2, Qiannan Fang3, Song-Guo Zheng4.   

Abstract

Regulatory T cells (Treg) play an indispensable role in maintaining the body's immune nonresponse to self-antigens and suppressing the body's unwarranted and potentially harmful immune responses. Their absence, reduction, dysfunction, transformation, and instability can lead to numerous autoimmune diseases. There are several distinct subtypes of the Treg cells, although they share certain biological characteristics and have unique phenotypes with different regulatory functions, as well as mechanistic abilities. In this book chapter, we introduce the latest advances in Treg cell subtypes pertaining to classification, phenotype, biological characteristics, and mechanisms. We also highlight the relationship between Treg cells and various diseases, including autoimmune, infectious, as well as tumors and organ transplants.

Entities:  

Keywords:  Cell therapy; Classification; Immune response; Immunological diseases; Treg cells

Mesh:

Substances:

Year:  2021        PMID: 33523440     DOI: 10.1007/978-981-15-6407-9_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  257 in total

1.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

2.  Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.

Authors:  Baharak Bahmani; Mayuko Uehara; Liwei Jiang; Farideh Ordikhani; Naima Banouni; Takaharu Ichimura; Zhabiz Solhjou; Georg J Furtmüller; Gerald Brandacher; David Alvarez; Ulrich H von Andrian; Kenji Uchimura; Qiaobing Xu; Ishaan Vohra; Osman A Yilmam; Yousef Haik; Jamil Azzi; Vivek Kasinath; Jonathan S Bromberg; Martina M McGrath; Reza Abdi
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

3.  Telomere reduction in scleroderma patients: a possible cause for chromosomal instability.

Authors:  C M Artlett; C M Black; D C Briggs; C O Stevens; K I Welsh
Journal:  Br J Rheumatol       Date:  1996-08

4.  A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

Authors:  Amit Awasthi; Yijun Carrier; Jean P S Peron; Estelle Bettelli; Masahito Kamanaka; Richard A Flavell; Vijay K Kuchroo; Mohamed Oukka; Howard L Weiner
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

5.  Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells.

Authors:  Marcel Batten; Noelyn M Kljavin; Ji Li; Michael J Walter; Frederic J de Sauvage; Nico Ghilardi
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

6.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

Authors:  Laetitia Agostini; Fabio Martinon; Kimberly Burns; Michael F McDermott; Philip N Hawkins; Jürg Tschopp
Journal:  Immunity       Date:  2004-03       Impact factor: 31.745

7.  Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4.

Authors:  R Bacchetta; R de Waal Malefijt; H Yssel; J Abrams; J E de Vries; H Spits; M G Roncarolo
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

Review 8.  From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation.

Authors:  Rosa Bacchetta; Federica Barzaghi; Maria-Grazia Roncarolo
Journal:  Ann N Y Acad Sci       Date:  2016-02-25       Impact factor: 5.691

9.  Helios expression is a marker of T cell activation and proliferation.

Authors:  Tatiana Akimova; Ulf H Beier; Liqing Wang; Matthew H Levine; Wayne W Hancock
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

10.  High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.

Authors:  R Bacchetta; M Bigler; J L Touraine; R Parkman; P A Tovo; J Abrams; R de Waal Malefyt; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more
  1 in total

1.  CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome.

Authors:  Sujan Ravendran; Sabina Sánchez Hernández; Saskia König; Rasmus O Bak
Journal:  Front Genome Ed       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.